Profil Institute Teams Up With American Diabetes Association to ‘Step Out’ Against Diabetes

Profil Institute Teams Up With American Diabetes Association to ‘Step Out’ Against Diabetes

SAN DIEGO, October 22, 2013 – Profil Institute for Clinical Research, Inc., a company providing science-driven early phase diabetes and obesity clinical research, celebrates its 9th year as a corporate sponsor of San Diego’s Step Out: Walk to Stop Diabetes, hosted by the American Diabetes Association (ADA).

The ADA’s Step Out Walk raises about $20 million annually on a national level with more than 150 walks taking place in over 100 U.S. cities.  The Step Out Walk in San Diego will take place Sunday, October 27 at De Anza Cove on Mission Bay.  More information can be found at San Diego Step Out homepage or to join or support Profil Institute’s team of walkers, please visit Profil Institute’s Step Out team homepage.

“The event itself is truly inspirational when witnessing so many people and businesses united together for a cause as vitally important as preventing diabetes and raising funds for a cure,” said Dr. Marcus Hompesch, Profil Institute President and CEO. “For that reason, Profil Institute is proud to be teaming up with the ADA to support the diabetes community and for its Step Out fundraising event here in San Diego.”

About Profil® Institute for Clinical Research, Inc.
Profil Institute is a Center of Excellence performing early phase clinical research of drugs and devices for diabetes and obesity and providing scientific support for metabolic drug target profiling, clinical development planning, publication activities and the establishment of scientific advisory boards. The company’s scientific expertise, metabolic clinical research methodologies, and automated glucose clamp technology enable Profil Institute to execute highly complex studies and have led Profil Institute to be a highly regarded clinical research institute for early phase diabetes drug studies. Profil Institute has been involved with every clinically relevant drug class in diabetes and in more than 200 clinical studies since the company’s inception in 2004. For more information, visit

About American Diabetes Association
The ADA is the nation’s leading non-profit charity providing diabetes research, information and advocacy. Each year, hundreds of thousands of people participate in ADA fund-raising events across the country to increase awareness and raise millions of dollars in the fight against this disease. Founded in 1940, the Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For more information about the ADA, visit

For further information about this press release, please contact:
Abby Devine
Profil Institute for Clinical Research, Inc.
Corporate Communications